Literature DB >> 203231

Azaribine (triacetyl-6-azauridine) in psoriasis. Screening by in vitro methods.

W Raab, B Gmeiner, P Muckenhuber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 203231     DOI: 10.1007/bf00561422

Source DB:  PubMed          Journal:  Arch Dermatol Res            Impact factor:   3.017


× No keyword cloud information.
  11 in total

1.  Double-blind controlled crossover high-dose study of Azaribine in psoriasis.

Authors:  W A Crutcher; S L Moschella
Journal:  Br J Dermatol       Date:  1975-02       Impact factor: 9.302

2.  [Antipsoriatic effect of dithranol (anthralin). 1].

Authors:  W Raab
Journal:  Hautarzt       Date:  1975-09       Impact factor: 0.751

3.  THE EFFECT OF TRIACETYL AZAURIDINE ON PSORIASIS.

Authors:  R W TURNER; P CALABRESI
Journal:  J Invest Dermatol       Date:  1964-12       Impact factor: 8.551

4.  Low dose azaribine in the treatment of psoriasis.

Authors:  P I Dantzig; B McEvoy; J Mauro; S Rayhanzadeh
Journal:  Br J Dermatol       Date:  1974-11       Impact factor: 9.302

5.  Anemia of azaribine in the treatment of psoriasis.

Authors:  R C Cornell; H G Milstein; R M Fox; R B Stoughton
Journal:  Arch Dermatol       Date:  1976-12

6.  Beneficial effects of triacetyl azauridine in psoriasis and mycosis fungoides.

Authors:  P Calabresi; R W Turner
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

7.  In vitro evaluation of methotrexate and azathioprine for antipsoriatic activity.

Authors:  W Raab; B Gmeiner
Journal:  Arch Dermatol Res       Date:  1975-08-29       Impact factor: 3.017

8.  The treatment of psoriasis with azaribine.

Authors:  D G Deneau; E M Farber
Journal:  Dermatologica       Date:  1975

9.  Dithranol (anthralin) versus triacetoxyanthracene. Investigations in vitro.

Authors:  W Raab
Journal:  Br J Dermatol       Date:  1976-08       Impact factor: 9.302

10.  Treatment of psoriatic arthritis with azaribine.

Authors:  S Levine; H E Paulus
Journal:  Arthritis Rheum       Date:  1976 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.